RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Cash from operations

ABEONA THERAPEUTICS INC.ABEO

Market cap
$248.11M
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2024-56+51.36%
Dec 31, 2023-37-14.92%
Dec 31, 2022-43-33.79%
Dec 31, 2021-66+87.61%
Dec 31, 2020-35-44.26%
Dec 31, 2019-63+60.62%
Dec 31, 2018-39+70.53%
Dec 31, 2017-23+76.23%
Dec 31, 2016-13+24.86%
Dec 31, 2015-10+546.99%
Dec 31, 2014-2-161200.00%
Dec 31, 20130-100.03%
Dec 31, 2012-4-48.02%
Dec 31, 2011-8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)